Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on September 8, 2025
Scientists Find Yoga Less Effective Than Traditional Exercise in Improving Vascular and Heart Function
EIN Presswire
·
September 8, 2025
In reviewing the scientific literature, researchers tend to downplay yoga's effectiveness in enhancing vascular and heart health SHARJAH, EMIRATE OF SHARJAH, UNITED ARAB EMIRATES, September 8, 2025 /EINPresswire.com/ -- Contrary to widespread belief, …
KFSHRC Inaugurates the Middle East’s First Smart Neuroscience Ward
EIN Presswire
·
September 8, 2025
RIYADH, SAUDI ARABIA, September 8, 2025 /EINPresswire.com/ -- Saudi Arabia, Riyadh: King Faisal Specialist Hospital …
Evoq Technologies is Exhibiting at Vision Expo LaunchPad Showcase in Las Vegas September 18-20 2025
EIN Presswire
·
September 8, 2025
A New Chapter in Eye Care HENDERSON, NV, UNITED STATES, September 8, 2025 /EINPresswire.com/ -- Vision EXPO West Venetian Exp, Las Vegas, Nevada, Sept 18-20 Stand LP12 https://west.visionexpo.com/en-us.html#/ Evoq Technologies is introducing …
Global Cervical Cancer Screening Market Size to Reach USD 12.41 Billion by 2034, Growing at 5.8% CAGR
EIN Presswire
·
September 8, 2025
The global cervical cancer screening market size was approximately USD 7.90 billion in 2024 and is projected to reach around USD 12.41 billion by 2034 PUNE, MAHARASHTRA, INDIA, September 8, 2025 /EINPresswire.com/ -- 1. Executive Summary The global …
PDRN Topicals Market to Hit USD 805.9 Million by 2035, Registering 9.8% CAGR from 2025 States Fact.MR
EIN Presswire
·
September 8, 2025
PDRN Topicals Market Analysis, By Formulation (Serums …
bYoRNA raises €1.5M to revolutionize mRNA manufacturing
EIN Presswire
·
September 8, 2025
bYoRNA raises €1.5M to advance yeast-based therapeutic mRNA, enabling longer, more efficient and affordable RNA for oncology, vaccines …
Dr. Peter J. Favaro Launches Bad People Bible: A Groundbreaking Guide to Removing Toxic People from Your Life
EIN Presswire
·
September 8, 2025
This new book combines clinical and forensic expertise with digital tools to help you spot and eliminate toxic people for good. NEW YORK, NY, UNITED STATES, September 8, 2025 /EINPresswire.com/ -- Renowned clinical and forensic psychologist Dr. Peter J. …
Riyadh to Host the First Edition of BIO Middle East
EIN Presswire
·
September 8, 2025
The event will become the region’s first ever biotechnology event in the health sector. RIYADH, SAUDI ARABIA, September 8, 2025 /EINPresswire.com/ -- The Saudi Ministry of Health has announced the launch of the first edition of BIO Middle East, the …
AWARE SECURES $7.5 MILLION IN SENATE APPROPRIATIONS BILL FOR IMPROVING ARMY HEARING PROTECTION - SUPPORTING WARFIGHTERS
EIN Presswire
·
September 8, 2025
Supporting Warfighters in the Army, Navy, Air Force, and Marine Corps WASHINGTON, DC, UNITED STATES, September 8, 2025 /EINPresswire.com/ -- The U.S. Senate recently advanced its Fiscal Year 2026 Defense Appropriations bill, providing an additional $7.5 …
Biomed Industries to Present Phase 2 Results on NA-931-An Oral Alternative to Injectables for Obesity- EASD 2025 Austria
EIN Presswire
·
September 8, 2025
Biomed Industries, Inc. to Present Phase 2 Results on NA-931-a First-in Class Alternative to Injectables for the Treatment of Obesity-EASD 2025- Vienna-Austria SAN JOSE, CA, UNITED STATES, September 8, 2025 /EINPresswire.com/ -- Biomed Industries, Inc. …
Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030
GlobeNewswire
·
September 8, 2025
NASHVILLE, Tenn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the pricing of its private offering (the “Offering”) of $250.0 million aggregate …
NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
GlobeNewswire
·
September 8, 2025
TORONTO and HAIFA, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a pioneering biopharmaceutical company developing exosome-based regenerative therapies, is pleased to …
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)
GlobeNewswire
·
September 8, 2025
LOUISVILLE, Ky., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Sanofi for Wayrilz (rilzabrutinib), which has been approved by the U.S. Food and Drug …
Sienna Senior Living Announces the Opening of Its Long-Term Care Community in North Bay and Retirement Community in Brantford, Ontario
GlobeNewswire
·
September 8, 2025
MARKHAM, Ontario, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) announced today that it has officially opened its Northern Heights Community, the Company’s first completed long-term care redevelopment …
PharmAla Completes Import of LaNeo MDMA for US Distribution
GlobeNewswire
·
September 8, 2025
TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …
Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang
GlobeNewswire
·
September 8, 2025
LOS ANGELES, CA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“Immix”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced that …
Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
GlobeNewswire
·
September 8, 2025
At Week 96 participants experienced even greater reductions in daily cornstarch intake while maintaining low levels of hypoglycemia, improved levels of euglycemia and improved fasting tolerance Phase 3 results are further supported by early data from open- …
Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference
GlobeNewswire
·
September 8, 2025
Wilmington, DE, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will now present at the Baird 2025 Global Healthcare Conference at 2:35 p.m. ET on …
Rapport Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
September 8, 2025
BOSTON and SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025
GlobeNewswire
·
September 8, 2025
EDEN PRAIRIE, Minn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from …